Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 295 articles:
HTML format



Single Articles


    November 2022
  1. NUNES CC, Sita A, Mallmann L, Birlem GE, et al
    HIV-1 genetic diversity and transmitted drug resistance to integrase strand transfer inhibitors among recently diagnosed adults in Porto Alegre, South Brazil.
    J Antimicrob Chemother. 2022;77:3510-3514.
    PubMed     Abstract available


  2. KOCER K, Boutin S, Heeg K, Nurjadi D, et al
    The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales.
    J Antimicrob Chemother. 2022;77:3487-3495.
    PubMed     Abstract available


  3. NORDMANN P, Bouvier M, Poirel L, Sadek M, et al
    Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales.
    J Antimicrob Chemother. 2022;77:3456-3461.
    PubMed     Abstract available


  4. NTAMATUNGIRO AJ, Kagura J, Weisser M, Francis JM, et al
    Pre-treatment HIV-1 drug resistance in antiretroviral therapy-naive adults in Eastern Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:3231-3241.
    PubMed     Abstract available


  5. DE DIOS R, Gadar K, McCarthy RR
    A high-efficiency scar-free genome-editing toolkit for Acinetobacter baumannii.
    J Antimicrob Chemother. 2022;77:3390-3398.
    PubMed     Abstract available


  6. GILL CM, Nicolau DP
    Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022 Nov 22:dkac385. doi: 10.1093.
    PubMed     Abstract available


  7. CASTRO BE, Rios R, Carvajal LP, Vargas ML, et al
    Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794061. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  8. HENERICO S, Lyimo E, Makubi AN, Magesa D, et al
    Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
    J Antimicrob Chemother. 2022;77:3138-3143.
    PubMed     Abstract available


  9. SCHALKWIJK HH, Gillemot S, Reynders M, Selleslag D, et al
    Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
    J Antimicrob Chemother. 2022;77:3153-3162.
    PubMed     Abstract available


  10. DAY J, Afshar B, Rowlands RS, Umer TS, et al
    Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark.
    J Antimicrob Chemother. 2022;77:3126-3129.
    PubMed     Abstract available


  11. PITT R, Boampong D, Day M, Jensen JS, et al
    Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium.
    J Antimicrob Chemother. 2022;77:2901-2907.
    PubMed     Abstract available


  12. MORENO-MORALES J, Guardiola S, Balleste-Delpierre C, Giralt E, et al
    A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogens.
    J Antimicrob Chemother. 2022;77:3077-3085.
    PubMed     Abstract available


  13. SUN RY, Guo WY, Zhang JX, Wang MG, et al
    Phylogenomic analysis of Salmonella Indiana ST17, an emerging MDR clonal group in China.
    J Antimicrob Chemother. 2022;77:2937-2945.
    PubMed     Abstract available


  14. AYFAN AKS, Macdonald J, Irwin AD, Zowawi HM, et al
    Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2022;77:2933-2936.
    PubMed     Abstract available


  15. DE JONG A, El Garch F, Hocquet D, Prenger-Berninghoff E, et al
    European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6750681. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  16. SHRESTHA R, Luterbach CL, Dai W, Komarow L, et al
    Characteristics of community-acquired carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022;77:2763-2771.
    PubMed     Abstract available


  17. GROHS P, Vilfaillot A, Zahar JR, Barbut F, et al
    Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
    J Antimicrob Chemother. 2022;77:2667-2678.
    PubMed     Abstract available


  18. BRENCIANI A, Morroni G, Schwarz S, Giovanetti E, et al
    Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
    J Antimicrob Chemother. 2022;77:2596-2621.
    PubMed     Abstract available


  19. BECKER J, Perreten V, Schupbach-Regula G, Stucki D, et al
    Associations of antimicrobial use with antimicrobial susceptibility at the calf level in bacteria isolated from the respiratory and digestive tracts of veal calves before slaughter.
    J Antimicrob Chemother. 2022;77:2859-2866.
    PubMed     Abstract available


  20. AULICINO PC, Momin Z, Rozenszajn M, Monzon A, et al
    HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H.
    J Antimicrob Chemother. 2022;77:2793-2802.
    PubMed     Abstract available


  21. HAENNI M, Boulouis HJ, Lagree AC, Drapeau A, et al
    Enterobacterales high-risk clones and plasmids spreading blaESBL/AmpC and blaOXA-48 genes within and between hospitalized dogs and their environment.
    J Antimicrob Chemother. 2022;77:2754-2762.
    PubMed     Abstract available


  22. LI J, Fan Q, Zuo J, Xue B, et al
    Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730836. doi: 10.1093.
    PubMed     Abstract available


  23. TANAKA E, Wajima T, Nakaminami H, Uchiya KI, et al
    Alternative quinolone-resistance pathway caused by simultaneous horizontal gene transfer in Haemophilus influenzae.
    J Antimicrob Chemother. 2022 Sep 19. pii: 6704850. doi: 10.1093.
    PubMed     Abstract available


  24. TORUMKUNEY D, Aktas Z, Unal S, van Hasselt J, et al
    Country data on AMR in Turkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  25. TORUMKUNEY D, Kozlov R, Sidorenko S, Kamble P, et al
    Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  26. TORUMKUNEY D, Kundu S, Vu GV, Nguyen HA, et al
    Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  27. TORUMKUNEY D, Nijhara P, Beltrame CO, Baisch EQ, et al
    Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  28. TORUMKUNEY D, Jamil B, Nizamuddin S, van Hasselt J, et al
    Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  29. TORUMKUNEY D, de la Torre C, Langfeld K, Lopez-Turrent NP, et al
    Country data on AMR in Mexico in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  30. TORUMKUNEY D, Dolgum S, van Hasselt J, Abdullah W, et al
    Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  31. TORUMKUNEY D, Poojary A, Shenoy B, Nijhara P, et al
    Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  32. TORUMKUNEY D, Behbehani N, van Hasselt J, Hamouda M, et al
    Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  33. RIGATTO MH, Ramos F, Barros A, Pedroso S, et al
    Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
    J Antimicrob Chemother. 2022 Sep 1. pii: 6681124. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  34. DIAZ-GARCIA J, Gomez A, Machado M, Alcala L, et al
    Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris.
    J Antimicrob Chemother. 2022 Aug 29. pii: 6678135. doi: 10.1093.
    PubMed     Abstract available


  35. MULLALLY C, Stubbs KA, Thai VC, Anandan A, et al
    Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase.
    J Antimicrob Chemother. 2022;77:2441-2447.
    PubMed     Abstract available


  36. YANG F, Gao S, Yan J, Lin X, et al
    Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model.
    J Antimicrob Chemother. 2022;77:2461-2469.
    PubMed     Abstract available


  37. WANG G, Wu P, Tang R, Zhang W, et al
    Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2353-2363.
    PubMed     Abstract available


  38. KHOUJA T, Tadrous M, Suda KJ
    Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)-authors' response.
    J Antimicrob Chemother. 2022 Aug 18. pii: 6670898. doi: 10.1093.
    PubMed    


  39. FONG W, Timms V, Sim E, Pey K, et al
    Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667673. doi: 10.1093.
    PubMed     Abstract available


  40. NUESCH-INDERBINEN M, Biggel M, Zurfluh K, Treier A, et al
    Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667639. doi: 10.1093.
    PubMed     Abstract available


  41. MURRAY CJL
    BSAC Vanguard Series: Tracking the global rise of antimicrobial resistance.
    J Antimicrob Chemother. 2022 Aug 5. pii: 6656168. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  42. ROGERS TR, Verweij PE, Castanheira M, Dannaoui E, et al
    Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
    J Antimicrob Chemother. 2022;77:2053-2073.
    PubMed     Abstract available


  43. ZHAI W, Wang T, Yang D, Zhang Q, et al
    Clonal relationship of tet(X4)-positive Escherichia coli ST761 isolates between animals and humans.
    J Antimicrob Chemother. 2022;77:2153-2157.
    PubMed     Abstract available


  44. KRUGER H, Ji X, Hanke D, Schink AK, et al
    Novel macrolide-lincosamide-streptogramin B resistance gene erm(54) in MRSA ST398 from Germany.
    J Antimicrob Chemother. 2022;77:2296-2298.
    PubMed    


  45. KIRUTHIKA S, Bhat R, Jayaram B, Vivekanandan P, et al
    A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus.
    J Antimicrob Chemother. 2022;77:2120-2124.
    PubMed     Abstract available


  46. BONCOMPAGNI SR, Micieli M, Di Maggio T, Aiezza N, et al
    Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens.
    J Antimicrob Chemother. 2022;77:2199-2208.
    PubMed     Abstract available


  47. KUFEL WD, Abouelhassan Y, Steele JM, Gutierrez RL, et al
    Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648989. doi: 10.1093.
    PubMed     Abstract available


  48. SEALEY JE, Hammond A, Mounsey O, Gould VC, et al
    Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
    J Antimicrob Chemother. 2022 Jul 20. pii: 6645196. doi: 10.1093.
    PubMed     Abstract available


  49. EMERAUD C, Godmer A, Girlich D, Vanparis O, et al
    Activity of mecillinam against carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Jul 11. pii: 6639593. doi: 10.1093.
    PubMed     Abstract available


  50. KO D, Choi SH
    Mechanistic understanding of antibiotic resistance mediated by EnvZ/OmpR two-component system in Salmonella enterica serovar Enteritidis.
    J Antimicrob Chemother. 2022 Jul 4. pii: 6628285. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  51. HACKMANN C, Gastmeier P, Schwarz S, Lubke-Becker A, et al
    Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis-authors' response.
    J Antimicrob Chemother. 2022;77:2043.
    PubMed    


  52. ROZENSZAJN M, Arazi-Caillaud S, Taicz M, Bologna R, et al
    HIV-1 pretreatment drug resistance in vertically infected children is associated with poor virological response to protease inhibitor (PI)-based first-line antiretroviral therapy (ART): results from a cohort study in Argentina.
    J Antimicrob Chemother. 2022;77:1969-1973.
    PubMed     Abstract available


  53. LAN Y, Li F, Li L, Deng X, et al
    Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China.
    J Antimicrob Chemother. 2022;77:1960-1968.
    PubMed     Abstract available


  54. ENGONE-ONDO JD, Bignoumba M, Boundzanga Moussavou P, Gafou A, et al
    HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa.
    J Antimicrob Chemother. 2022;77:2035-2037.
    PubMed    


  55. TORRENS G, van der Schalk TE, Cortes-Lara S, Timbermont L, et al
    Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
    J Antimicrob Chemother. 2022;77:1862-1872.
    PubMed     Abstract available


  56. EL-QUSHAYRI AE, Ghozy S
    Comment on: Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis.
    J Antimicrob Chemother. 2022;77:2042.
    PubMed    


  57. MITCHELL J, O'Neill AJ, King R
    Creating a framework to align antimicrobial resistance (AMR) research with the global guidance: a viewpoint.
    J Antimicrob Chemother. 2022 Jun 24. pii: 6617339. doi: 10.1093.
    PubMed     Abstract available


  58. GINEVRA C, Beraud L, Pionnier I, Sallabery K, et al
    Detection of highly macrolide-resistant Legionella pneumophila strains from a hotel water network using systematic whole-genome sequencing.
    J Antimicrob Chemother. 2022 Jun 9. pii: 6604636. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  59. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of an MDR Lactobacillus salivarius isolate harbouring the phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2022 May 31. pii: 6595591. doi: 10.1093.
    PubMed     Abstract available


  60. SULIS G, Pai M, Gandra S
    Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 May 31. pii: 6595593. doi: 10.1093.
    PubMed    


  61. NAHA S, Sands K, Mukherjee S, Dutta S, et al
    A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics.
    J Antimicrob Chemother. 2022;77:1586-1591.
    PubMed     Abstract available


  62. LIU P, Qin X, Cao T, Yang Y, et al
    Telithromycin resistance in Campylobacter mediated by 23S rRNA A2075G mutation and erm(B).
    J Antimicrob Chemother. 2022;77:1557-1560.
    PubMed     Abstract available


  63. REVOLLO B, Vinuela L, de la Mora L, Garcia F, et al
    Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.
    J Antimicrob Chemother. 2022;77:1738-1740.
    PubMed     Abstract available


  64. JAUNEIKAITE E, Honeyford K, Blandy O, Mosavie M, et al
    Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
    J Antimicrob Chemother. 2022;77:1753-1761.
    PubMed     Abstract available


  65. LUQUE-PAZ D, Bennis Y, Jaubert P, Dubee V, et al
    Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    J Antimicrob Chemother. 2022;77:1787-1789.
    PubMed    


  66. OUESLATI S, Raymond J, Croue M, Carvahlo L, et al
    MDR bacterial isolates in environmental samples from Kinshasa, Democratic Republic of the Congo.
    J Antimicrob Chemother. 2022;77:1785-1787.
    PubMed    


  67. IWUJI C, Pillay D, Shamu P, Murire M, et al
    A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.
    J Antimicrob Chemother. 2022 May 17. pii: 6586623. doi: 10.1093.
    PubMed     Abstract available


  68. BRAZIER A, Merriam S, Halpern D
    BSAC Vanguard Series: Behavioural science and antimicrobial resistance.
    J Antimicrob Chemother. 2022 May 16. pii: 6586211. doi: 10.1093.
    PubMed     Abstract available


  69. GOLPARIAN D, Kittiyaowamarn R, Paopang P, Sangprasert P, et al
    Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
    J Antimicrob Chemother. 2022 May 11. pii: 6583486. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  70. ZHANG X, Shi S, Yao Z, Zheng X, et al
    Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574685. doi: 10.1093.
    PubMed     Abstract available


  71. BARENG OT, Moyo S, Zahralban-Steele M, Maruapula D, et al
    HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    J Antimicrob Chemother. 2022;77:1385-1395.
    PubMed     Abstract available


  72. GUPTA A, Landman D, Quale J
    Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:1282-1285.
    PubMed     Abstract available


  73. PACIOS O, Fernandez-Garcia L, Bleriot I, Blasco L, et al
    Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-beta-naphthylamide (PabetaN): co-resistance to antimicrobials.
    J Antimicrob Chemother. 2022;77:1272-1281.
    PubMed     Abstract available


  74. YANG D, Heederik DJJ, Scherpenisse P, Van Gompel L, et al
    Antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) abundance in animal faeces, meat, production environments and human faeces in Europe.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573562. doi: 10.1093.
    PubMed     Abstract available


  75. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    PubMed     Abstract available


  76. LIU C, Dong N, Zeng Y, Lu J, et al
    Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571571. doi: 10.1093.
    PubMed     Abstract available


  77. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    PubMed     Abstract available


  78. ENER B, Ergin C, Gulmez D, Agca H, et al
    Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571734. doi: 10.1093.
    PubMed     Abstract available


  79. SCHINK AK, Hanke D, Semmler T, Brombach J, et al
    Novel multiresistance-mediating integrative and conjugative elements carrying unusual antimicrobial resistance genes in Mannheimia haemolytica and Pasteurella multocida.
    J Antimicrob Chemother. 2022 Apr 18. pii: 6569420. doi: 10.1093.
    PubMed    


  80. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    PubMed     Abstract available


  81. FUCHS F, Becerra-Aparicio F, Xanthopoulou K, Seifert H, et al
    In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    J Antimicrob Chemother. 2022 Apr 12. pii: 6566767. doi: 10.1093.
    PubMed     Abstract available


  82. HARMER CJ, Lebreton F, Stam J, McGann PT, et al
    Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance.
    J Antimicrob Chemother. 2022 Apr 11. pii: 6566059. doi: 10.1093.
    PubMed     Abstract available


  83. CHARANI E
    BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance.
    J Antimicrob Chemother. 2022 Apr 6. pii: 6564004. doi: 10.1093.
    PubMed     Abstract available


  84. CHAIBEN V, Yamada CH, Telles JP, de Andrade AP, et al
    A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562691. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  85. SUN Z, Lan Y, Liang S, Wang J, et al
    Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.
    J Antimicrob Chemother. 2022;77:1119-1124.
    PubMed     Abstract available


  86. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    PubMed     Abstract available


  87. CHEUNG PK, Shahid A, Dong W, Lepik KJ, et al
    Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
    J Antimicrob Chemother. 2022;77:979-988.
    PubMed     Abstract available


  88. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    PubMed    


  89. AMBROSE SJ, Hamidian M, Hall RM
    Extensively resistant Acinetobacter baumannii isolate RCH52 carries several resistance genes derived from an IncC plasmid.
    J Antimicrob Chemother. 2022;77:930-933.
    PubMed     Abstract available


  90. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of the novel optrA-carrying pseudo-compound transposon Tn7363 and an Inc18 plasmid carrying cfr(D) in Vagococcus lutrae.
    J Antimicrob Chemother. 2022;77:921-925.
    PubMed     Abstract available


  91. MARGOT N, Vanderveen L, Naik V, Ram R, et al
    Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study.
    J Antimicrob Chemother. 2022;77:989-995.
    PubMed     Abstract available


  92. GOFF D
    BSAC Vanguard Series: The future of antibiotic stewardship-managing access and excess.
    J Antimicrob Chemother. 2022;77:863-864.
    PubMed     Abstract available


  93. TICKNER JA, Bradshaw CS, Murray GL, Whiley DM, et al
    Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    J Antimicrob Chemother. 2022 Mar 30. pii: 6555777. doi: 10.1093.
    PubMed     Abstract available


  94. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    PubMed    


  95. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    PubMed     Abstract available


  96. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    PubMed     Abstract available


  97. CREMANNS M, Lange F, Gatermann SG, Pfennigwerth N, et al
    Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Mar 10. pii: 6546017. doi: 10.1093.
    PubMed     Abstract available


  98. NEVILLE LF, Shalit I, Warn PA, Rendell JT, et al
    Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    J Antimicrob Chemother. 2022 Mar 1. pii: 6539950. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  99. DUBEY V, Devnath K, Gupta VK, Kalyan G, et al
    Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.
    J Antimicrob Chemother. 2022 Feb 24. pii: 6535191. doi: 10.1093.
    PubMed     Abstract available


  100. YAN L, Yu F, Liang J, Cheng Y, et al
    Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China.
    J Antimicrob Chemother. 2022;77:727-734.
    PubMed     Abstract available


  101. ELIAS P, Barraud O, El Hamel C, Chainier D, et al
    Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections.
    J Antimicrob Chemother. 2022;77:767-770.
    PubMed     Abstract available


  102. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    PubMed     Abstract available


  103. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    PubMed    


  104. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    PubMed     Abstract available


  105. HACHIYA A, Kubota M, Shigemi U, Ode H, et al
    Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitors.
    J Antimicrob Chemother. 2022;77:574-577.
    PubMed     Abstract available


  106. LOPEZ-DIAZ M, Ellaby N, Turton J, Woodford N, et al
    NDM-1 carbapenemase resistance gene vehicles emergent on distinct plasmid backbones from the IncL/M family.
    J Antimicrob Chemother. 2022;77:620-624.
    PubMed     Abstract available


  107. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    PubMed     Abstract available


  108. KHOUJA T, Mitsantisuk K, Tadrous M, Suda KJ, et al
    Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 Feb 18. pii: 6530407. doi: 10.1093.
    PubMed     Abstract available


  109. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    PubMed     Abstract available


  110. DARLOW CA, Farrington N, Johnson A, McEntee L, et al
    Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6529341. doi: 10.1093.
    PubMed     Abstract available


  111. SHI S, Zhang X, Yao Z, Xu M, et al
    Synergistic effect of the novel beta-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528648. doi: 10.1093.
    PubMed     Abstract available


  112. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    PubMed     Abstract available


  113. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    PubMed     Abstract available


  114. MENDELSON M
    BSAC Vanguard Series: Inequality and antibiotic resistance.
    J Antimicrob Chemother. 2022;77:277-278.
    PubMed     Abstract available


  115. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  116. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2022;77:400-408.
    PubMed     Abstract available


  117. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  118. HENERICO S, Mikasi SG, Kalluvya SE, Brauner JM, et al
    Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania.
    J Antimicrob Chemother. 2022;77:483-491.
    PubMed     Abstract available


  119. DUAN Y, Liu S, Gao Y, Zhang P, et al
    Macrolides mediate transcriptional activation of the msr(E)-mph(E) operon through histone-like nucleoid-structuring protein (HNS) and cAMP receptor protein (CRP).
    J Antimicrob Chemother. 2022;77:391-399.
    PubMed     Abstract available


  120. CASALONE E, Vignolini T, Braconi L, Gardini L, et al
    Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    J Antimicrob Chemother. 2022;77:413-424.
    PubMed     Abstract available


  121. EL BOUZIDI K, Datir RP, Kwaghe V, Roy S, et al
    Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.
    J Antimicrob Chemother. 2022;77:474-482.
    PubMed     Abstract available


  122. LE HINGRAT Q, Collin G, Damond F, Peytavin G, et al
    In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
    J Antimicrob Chemother. 2022;77:409-412.
    PubMed     Abstract available


  123. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    PubMed     Abstract available


  124. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    PubMed     Abstract available


    January 2022
  125. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    PubMed    


  126. SHINTANI M, Suzuki H, Nojiri H, Suzuki M, et al
    Precise classification of antimicrobial resistance-associated IncP-2 megaplasmids for molecular epidemiological studies on Pseudomonas species.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515317. doi: 10.1093.
    PubMed    


  127. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    PubMed     Abstract available


  128. YANG D, Heederik DJJ, Mevius DJ, Scherpenisse P, et al
    Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries.
    J Antimicrob Chemother. 2022 Jan 21. pii: 6513516. doi: 10.1093.
    PubMed     Abstract available


  129. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    PubMed     Abstract available


  130. MADER R, Bourely C, Amat JP, Broens EM, et al
    Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach.
    J Antimicrob Chemother. 2022 Jan 12. pii: 6504034. doi: 10.1093.
    PubMed     Abstract available


  131. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    PubMed     Abstract available


  132. WELLS D
    BSAC Vanguard Series: The future role of laboratories in relation to antimicrobial resistance.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503859. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  133. ESSACK S
    BSAC Vanguard Series: From treatment options to precision medicine: the future of 'omics-based' antibiotic resistance surveillance data.
    J Antimicrob Chemother. 2021;77:5-6.
    PubMed     Abstract available


  134. OSTERHOLM MT
    BSAC Vanguard Series: the future of ADVOCACY on AMR.
    J Antimicrob Chemother. 2021;77:1-2.
    PubMed     Abstract available


  135. BERMAN D, Neale R
    BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    J Antimicrob Chemother. 2021;77:3-4.
    PubMed     Abstract available


  136. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    PubMed     Abstract available


  137. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    PubMed     Abstract available


  138. HUANG SW, Shen MC, Wang WH, Li WY, et al
    High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.
    J Antimicrob Chemother. 2021;77:185-195.
    PubMed     Abstract available


  139. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    PubMed     Abstract available


  140. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    PubMed     Abstract available


  141. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    PubMed     Abstract available


  142. HOWARD-ANDERSON J, Davis M, Page AM, Bower CW, et al
    Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464149. doi: 10.1093.
    PubMed     Abstract available


  143. TELLO M, Oporto B, Lavin JL, Ocejo M, et al
    Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring blaNDM-1 in an IncC plasmid.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6462046. doi: 10.1093.
    PubMed    


  144. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    PubMed     Abstract available


  145. LIU G, Thomsen LE, Olsen JE
    Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459601. doi: 10.1093.
    PubMed     Abstract available


  146. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    PubMed     Abstract available


  147. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    PubMed     Abstract available


  148. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    PubMed     Abstract available


  149. SUN S, Wang Q, Jin L, Guo Y, et al
    Identification of multiple transfer units and novel subtypes of tmexCD-toprJ gene clusters in clinical carbapenem-resistant Enterobacter cloacae and Klebsiella oxytoca.
    J Antimicrob Chemother. 2021 Dec 7. pii: 6454463. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  150. VOSS A
    BSAC Vanguard Series: The future of infection prevention and control: how COVID is already transforming our approach to antimicrobial resistance.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440021. doi: 10.1093.
    PubMed     Abstract available


  151. DAVIES DS
    BSAC Vanguard Series: Are we finally finding our voice on antimicrobial resistance?
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440039. doi: 10.1093.
    PubMed     Abstract available


  152. HAYWARD G, Turner P
    BSAC Vanguard Series: Antimicrobial resistance and the future of diagnostic testing.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440024. doi: 10.1093.
    PubMed     Abstract available


  153. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    PubMed     Abstract available


  154. BOUZA E
    The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  155. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427458. doi: 10.1093.
    PubMed     Abstract available


  156. MONTEJANO R, Dominguez-Dominguez L, de Miguel R, Rial-Crestelo D, et al
    Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
    J Antimicrob Chemother. 2021;76:3263-3271.
    PubMed     Abstract available


  157. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


  158. DELORY T, Le Bel J, Lariven S, Peiffer-Smadja N, et al
    Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423107. doi: 10.1093.
    PubMed     Abstract available


  159. LIEPA R, Mann R, Osman M, Hamze M, et al
    Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain.
    J Antimicrob Chemother. 2021 Nov 6. pii: 6422573. doi: 10.1093.
    PubMed     Abstract available


  160. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    PubMed    


    October 2021
  161. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


  162. GUILLOTEAU H, Pradalier C, Roman VL, Bellanger X, et al
    Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay.
    J Antimicrob Chemother. 2021 Oct 21. pii: 6407543. doi: 10.1093.
    PubMed     Abstract available


  163. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Oct 20. pii: 6403927. doi: 10.1093.
    PubMed     Abstract available


  164. NDASHIMYE E, Li Y, Reyes PS, Avino M, et al
    High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
    J Antimicrob Chemother. 2021;76:2965-2974.
    PubMed     Abstract available


  165. XIE YN, Zhu FX, Zhong YT, Chen YT, et al
    Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    J Antimicrob Chemother. 2021;76:2975-2982.
    PubMed     Abstract available


  166. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    PubMed    


  167. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    PubMed     Abstract available


  168. DE LAZZARI E, Gonzalez-Cordon A, Inciarte A, Ugarte A, et al
    Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort.
    J Antimicrob Chemother. 2021;76:2988-2992.
    PubMed     Abstract available


  169. CHARPENTIER C, Storto A, Soulie C, Ferre VM, et al
    Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
    J Antimicrob Chemother. 2021;76:2983-2987.
    PubMed     Abstract available


  170. HE YZ, Kuang X, Long TF, Li G, et al
    Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    J Antimicrob Chemother. 2021 Oct 6. pii: 6382243. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  171. BARRAUD O, Guichard E, Chainier D, Postil D, et al
    Integrons, a predictive biomarker for antibiotic resistance in acute sepsis: the IRIS study.
    J Antimicrob Chemother. 2021 Sep 24. pii: 6374797. doi: 10.1093.
    PubMed     Abstract available


  172. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    PubMed     Abstract available


  173. AMBROSE SJ, Hall RM
    Origin of the dfrA44 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371308. doi: 10.1093.
    PubMed    


  174. BANGALEE A, Hans L, Steegen K
    Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    J Antimicrob Chemother. 2021;76:2659-2665.
    PubMed     Abstract available


  175. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  176. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  177. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  178. GILL CM, Abdelraouf K, Oota M, Nakamura R, et al
    Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
    J Antimicrob Chemother. 2021;76:2615-2621.
    PubMed     Abstract available


  179. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    PubMed    


  180. TOMCZYK S, Taylor A, Brown A, de Kraker MEA, et al
    Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362680. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  181. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  182. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  183. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    PubMed     Abstract available


  184. ZHU Y, Yang Q, Schwarz S, Yang W, et al
    Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA.
    J Antimicrob Chemother. 2021 Aug 18. pii: 6354200. doi: 10.1093.
    PubMed    


  185. HISCOX JA, Khoo SH, Stewart JP, Owen A, et al
    Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
    J Antimicrob Chemother. 2021;76:2230-2233.
    PubMed     Abstract available


  186. ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
    Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
    J Antimicrob Chemother. 2021;76:2394-2399.
    PubMed     Abstract available


  187. MARTIN C, Gracias S, Charpentier C, Descamps D, et al
    HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
    J Antimicrob Chemother. 2021;76:2306-2309.
    PubMed     Abstract available


  188. TAYLOR E, Bal AM, Balakrishnan I, Brown NM, et al
    A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.
    J Antimicrob Chemother. 2021;76:2428-2436.
    PubMed     Abstract available


  189. MARCELIN AG, Charpentier C, Bellecave P, Abdi B, et al
    Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
    J Antimicrob Chemother. 2021;76:2400-2406.
    PubMed     Abstract available


  190. WATERA C, Ssemwanga D, Namayanja G, Asio J, et al
    HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    J Antimicrob Chemother. 2021;76:2407-2414.
    PubMed     Abstract available


  191. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  192. WICKRAMAGE I, Spigaglia P, Sun X
    Mechanisms of antibiotic resistance of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327067. doi: 10.1093.
    PubMed     Abstract available


  193. LIU P, Hao Z, Liu M, Niu M, et al
    Genetic mutations in adaptive evolution of growth-independent vancomycin-tolerant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327451. doi: 10.1093.
    PubMed     Abstract available


  194. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  195. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.
    J Antimicrob Chemother. 2021;76:2061-2070.
    PubMed     Abstract available


  196. MILLIERE L, Bocket L, Tinez C, Robineau O, et al
    Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.
    J Antimicrob Chemother. 2021;76:2143-2147.
    PubMed     Abstract available


  197. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  198. BRENNER BG, Oliveira M, Ibanescu RI, Routy JP, et al
    Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.
    J Antimicrob Chemother. 2021;76:2137-2142.
    PubMed     Abstract available


  199. BIGGEL M, Zurfluh K, Treier A, Nuesch-Inderbinen M, et al
    Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples.
    J Antimicrob Chemother. 2021;76:2004-2011.
    PubMed     Abstract available


    June 2021
  200. AMBROSE SJ, Hall RM
    dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering.
    J Antimicrob Chemother. 2021 Jun 28. pii: 6310424. doi: 10.1093.
    PubMed     Abstract available


  201. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  202. LU HF, Tsai YC, Li LH, Lin YT, et al
    Role of AzoR, a LysR-type transcriptional regulator, in SmeVWX pump-mediated antibiotic resistance in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307154. doi: 10.1093.
    PubMed     Abstract available


  203. ZINNER SH, Alieva KN, Golikova MV, Strukova EN, et al
    Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
    J Antimicrob Chemother. 2021;76:1832-1839.
    PubMed     Abstract available


  204. HORNER C, Mushtaq S, Allen M, Longshaw C, et al
    Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
    J Antimicrob Chemother. 2021;76:1822-1831.
    PubMed     Abstract available


  205. LAUMEN JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, et al
    Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2021;76:1752-1758.
    PubMed     Abstract available


  206. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  207. JIMENEZ DE ORY S, Beltran-Pavez C, Gutierrez-Lopez M, Santos MDM, et al
    Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure.
    J Antimicrob Chemother. 2021;76:1886-1892.
    PubMed     Abstract available


  208. GISKE CG, Kahlmeter G, MacGowan A, Turnidge J, et al
    Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study.
    J Antimicrob Chemother. 2021;76:1949-1950.
    PubMed    


  209. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Erratum to: Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Jun 14. pii: 6298302. doi: 10.1093.
    PubMed    


    May 2021
  210. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  211. ABDI B, Chebbi M, Wirden M, Teyssou E, et al
    No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
    J Antimicrob Chemother. 2021;76:1553-1557.
    PubMed     Abstract available


  212. LI JZ, Stella N, Choudhary MC, Javed A, et al
    Impact of pre-existing drug resistance on risk of virological failure in South Africa.
    J Antimicrob Chemother. 2021;76:1558-1563.
    PubMed     Abstract available


  213. MERNISSI T, Bodeau S, Andre C, Zahr N, et al
    An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.
    J Antimicrob Chemother. 2021;76:1643-1646.
    PubMed    


  214. YADAV K, Garoff L, Huseby DL, Hughes D, et al
    Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2021;76:1441-1447.
    PubMed     Abstract available


  215. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  216. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  217. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  218. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  219. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  220. TRUSWELL A, Abraham R, O'Dea M, Lee ZZ, et al
    Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance.
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248215. doi: 10.1093.
    PubMed     Abstract available


  221. RAOULT D, Hadjadj L, Baron SA, Rolain JM, et al
    Role of glyphosate in the emergence of antimicrobial resistance in bacteria?
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248211. doi: 10.1093.
    PubMed     Abstract available


  222. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  223. AMBROSE SJ, Hall RM
    Identification of the dfrA4 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226985. doi: 10.1093.
    PubMed    


  224. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  225. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  226. DELAUGERRE C, Nere ML, Eymard-Duvernay S, Armero A, et al
    Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
    J Antimicrob Chemother. 2021;76:1286-1293.
    PubMed     Abstract available


  227. BROWN JA, Amstutz A, Nsakala BL, Seeburg U, et al
    Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    J Antimicrob Chemother. 2021;76:1294-1298.
    PubMed     Abstract available


  228. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  229. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  230. FELICIO MR, Silveira GGOS, Oshiro KGN, Meneguetti BT, et al
    Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2021;76:1174-1186.
    PubMed     Abstract available


  231. SEMENGUE ENJ, Armenia D, Inzaule S, Santoro MM, et al
    Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    J Antimicrob Chemother. 2021;76:1277-1285.
    PubMed     Abstract available


  232. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  233. MASHE T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, et al
    Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019.
    J Antimicrob Chemother. 2021;76:1160-1167.
    PubMed     Abstract available


  234. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  235. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  236. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  237. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  238. KRAGH KN, Gijon D, Maruri A, Antonelli A, et al
    Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
    J Antimicrob Chemother. 2021;76:1001-1009.
    PubMed     Abstract available


  239. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  240. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  241. ENGONE-ONDO JD, Mouinga-Ondeme A, Lekana-Douki SE, Diane A, et al
    High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy.
    J Antimicrob Chemother. 2021;76:1051-1056.
    PubMed     Abstract available


  242. JONES JC, Pascua PNQ, Harrington WN, Webby RJ, et al
    Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.
    J Antimicrob Chemother. 2021;76:957-960.
    PubMed     Abstract available


  243. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


    February 2021
  244. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  245. KAO SW, Liu ZH, Wu TS, Ku SW, et al
    Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    J Antimicrob Chemother. 2021;76:722-728.
    PubMed     Abstract available


  246. BUTLER DA, Rana AP, Krapp F, Patel SR, et al
    Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    J Antimicrob Chemother. 2021;76:671-679.
    PubMed     Abstract available


  247. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  248. PHAM HT, Alves BM, Yoo S, Xiao MA, et al
    Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.
    J Antimicrob Chemother. 2021;76:639-647.
    PubMed     Abstract available


  249. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


    January 2021
  250. TEMKIN E, Margalit I, Nutman A, Carmeli Y, et al
    Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  251. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  252. MACHUCA J, Recacha E, Gallego-Mesa B, Diaz-Diaz S, et al
    Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:338-344.
    PubMed     Abstract available


  253. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  254. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  255. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  256. HUA X, Moran RA, Xu Q, He J, et al
    Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2021;76:65-69.
    PubMed     Abstract available


  257. CHERNY SS, Nevo D, Baraz A, Baruch S, et al
    Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling.
    J Antimicrob Chemother. 2021;76:239-248.
    PubMed     Abstract available


  258. SALADINI F, Giammarino F, Hosseini BA, Giannini A, et al
    In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
    J Antimicrob Chemother. 2021;76:130-134.
    PubMed     Abstract available


  259. WENK BM, Mbunkah HA, Nsanwe NN, Mbu ET, et al
    Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
    J Antimicrob Chemother. 2021;76:124-129.
    PubMed     Abstract available


    December 2020
  260. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


    November 2020
  261. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  262. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed     Abstract available


  263. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed     Abstract available


  264. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  265. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  266. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  267. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  268. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  269. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  270. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  271. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  272. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  273. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


  274. LIM JM, Singh SR, Duong MC, Legido-Quigley H, et al
    Impact of national interventions to promote responsible antibiotic use: a systematic review.
    J Antimicrob Chemother. 2020;75:14-29.
    PubMed     Abstract available


  275. VISSEAUX B, Assoumou L, Mahjoub N, Grude M, et al
    Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
    J Antimicrob Chemother. 2020;75:183-193.
    PubMed     Abstract available


  276. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  277. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  278. TZOU PL, Rhee SY, Descamps D, Clutter DS, et al
    Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    J Antimicrob Chemother. 2020;75:170-182.
    PubMed     Abstract available


  279. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  280. RODRIGUEZ-VILLODRES A, Gil-Marques ML, Alvarez-Marin R, Bonnin RA, et al
    Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.
    J Antimicrob Chemother. 2020;75:77-85.
    PubMed     Abstract available


  281. MODICA S, Redi D, Gagliardini R, Giombini E, et al
    Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
    J Antimicrob Chemother. 2020;75:194-199.
    PubMed     Abstract available


  282. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  283. DORTET L, Broda A, Bernabeu S, Glupczynski Y, et al
    Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
    J Antimicrob Chemother. 2020;75:110-116.
    PubMed     Abstract available


  284. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  285. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  286. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  287. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  288. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  289. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  290. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  291. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  292. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


  293. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  294. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  295. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: